Virus Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Respiratory Syncytial Virus Epidemiology
Scientists at Erasmus University detail research in respiratory syncytial virus epidemiology
April 10th, 2007
Current study results from the report, "Recombinant human deoxyribonuclease in infants with respiratory syncytial virus bronchiolitis," have been published. According to recent research published in the journal Chest, "Treatment of hospitalized infants with respiratory syncytial virus (RSV) bronchiolitis is mainly supportive. Bronchodilators and systemic steroids are often used but do not reduce the length of hospital stay." "Because hypoxia and airways obstruction develop secondary to viscous mucus in infants with RSV bronchiolitis, and because free DNA is present in RSV mucus, we tested the efficacy of the mucolytic drug recombinant human deoxyribonuclease...
Source: Virus Weekly (2007-04-10)
|
